Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

Kai Juhani Kauppinen; Pia Kivelä; Jussi Sutinen

doi:10.1089/apc.2019.0236

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

Kai Juhani Kauppinen, Pia Kivelä, Jussi Sutinen

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	AIDS Patient Care and STDs
Volume	33
Issue number	12
Pages (from-to)	500-506
Number of pages	7
ISSN	1087-2914
DOIs	https://doi.org/10.1089/apc.2019.0236
Publication status	Published - Dec 2019
MoE publication type	A1 Journal article-refereed

Fields of Science

HIV
tenofovir disoproxil fumarate
tenofovir alafenamide
dyslipidemia
cholesterol
lipid-lowering effect
STATIN THERAPY
DOUBLE-BLIND
MYOCARDIAL-INFARCTION
LDL CHOLESTEROL
ADVERSE EVENTS
EZETIMIBE
EFFICACY
RISK
SAFETY
3142 Public health care science, environmental and occupational health
3121 General medicine, internal medicine and other clinical medicine

Access to Document

10.1089/apc.2019.0236

Cite this

@article{392cc8c8954e456ea79f02b5f6b1b9c0,

title = "Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting",

keywords = "HIV, tenofovir disoproxil fumarate, tenofovir alafenamide, dyslipidemia, cholesterol, lipid-lowering effect, STATIN THERAPY, DOUBLE-BLIND, MYOCARDIAL-INFARCTION, LDL CHOLESTEROL, ADVERSE EVENTS, EZETIMIBE, EFFICACY, RISK, SAFETY, 3142 Public health care science, environmental and occupational health, 3121 General medicine, internal medicine and other clinical medicine",

author = "Kauppinen, {Kai Juhani} and Pia Kivel{\"a} and Jussi Sutinen",

year = "2019",

month = dec,

doi = "10.1089/apc.2019.0236",

language = "English",

volume = "33",

pages = "500--506",

journal = "AIDS Patient Care and STDs",

issn = "1087-2914",

publisher = "Mary Ann Liebert",

number = "12",

}

TY - JOUR

T1 - Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

AU - Kauppinen, Kai Juhani

AU - Kivelä, Pia

AU - Sutinen, Jussi

PY - 2019/12

Y1 - 2019/12

KW - HIV

KW - tenofovir disoproxil fumarate

KW - tenofovir alafenamide

KW - dyslipidemia

KW - cholesterol

KW - lipid-lowering effect

KW - STATIN THERAPY

KW - DOUBLE-BLIND

KW - MYOCARDIAL-INFARCTION

KW - LDL CHOLESTEROL

KW - ADVERSE EVENTS

KW - EZETIMIBE

KW - EFFICACY

KW - RISK

KW - SAFETY

KW - 3142 Public health care science, environmental and occupational health

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1089/apc.2019.0236

DO - 10.1089/apc.2019.0236

M3 - Article

VL - 33

SP - 500

EP - 506

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 12

ER -